Intramuscular penicillin is more effective than oral penicillin in secondary prevention of rheumatic fever - A systematic review

South African Medical Journal

Volumn 93, Issue 3, 2003, Pages 212-218

  Manyemba, Juliet ^a   Mayosi, Bongani M ^b  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PENICILLIN G;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL TRIAL; COCHRANE LIBRARY; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG FORMULATION; DRUG INTERMITTENT THERAPY; EMBASE; HUMAN; MAJOR CLINICAL STUDY; MEDLINE; PHARYNGITIS; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RHEUMATIC FEVER; SECONDARY PREVENTION; STREPTOCOCCUS INFECTION;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; HUMANS; INJECTIONS, INTRAMUSCULAR; PENICILLINS; RHEUMATIC FEVER; STREPTOCOCCAL INFECTIONS;

EID: 0037367763     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. World Health Organisation/International Society and Federation of Cardiology. Strategy for controlling rheumatic fever/rheumatic heart disease with emphasis on prevention: memorandum from a joint WHO/ISFC meeting. Bull World Health Organ 1995; 73: 583-587.
2. Mayosi BM, Commerford PJ, Levetan BN. Anticoagulation for prosthetic valves during pregnancy. Clin Cardiol 1996; 19: 921.
3. Del Mar CB, Glasziou PP, Spinks AB. Antibiotics for sore throat (Cochrane Review). In: The Cochrane Library, Issue 2, 2002. Oxford: Update Software.
4. Tompkins DG, Baxerbaum B, Liebman J. Long-term prognosis of rheumatic fever patients receiving regular intramuscular benzathine penicillin. Circulation 1972; 45: 543-551.
5. Majeed HA, Batnager S, Yousof AM, Khuffash F, Yusuf AR. Acute rheumatic fever and the evolution of rheumatic heart disease: a prospective 12-year follow-up report. J Clin Epidemiol 1992; 45: 871-875.
6. World Health Organisation Cardiovascular Disease Unit. WHO Program for the prevention of rheumatic fever/rheumatic disease in 16 developing countries: report from Phase 1 (1986 - 90). Bull World Health Organ 1992; 70: 213-218.
7. Dajani A, Taubert K, Ferrieri P, et al. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: A Statement for Health Professionals. Pediatrics 1995; 96: 758-764.
8. Department of Health, South Aftica. National guidelines on primary prevention and prophylaxis of rheumatic fever and rheumatic disease for health professionals at primary level. S Afr Med J 1999; 89 (Suppl 2): C91-C94.
9. World Health Organisation Study Group. Rheumatic fever and rheumatic heart disease. World Health Organ Tech Rep Ser 1988; 764: 1-58.
10. Padmavati S. Rheumatic heart disease: prevalence and preventive measures in the Indian subcontinent. Heart 2001; 86: 127.
11. Jones TD. The diagnosis of rheumatic fever. JAMA 1944; 126: 481-486.
12. American Heart Association. Jones Criteria (modified) for Guidance in the Diagnosis of Rheumatic Fever: Report of the Committee on Standards and Criteria for Programs of Care. Circulation 1956; 13: 617-620.
13. Dajani AS, Ayoub E, Bierman FZ, et al. Guidelines for the diagnosis of rheumatic fever: Jones Criteria updated 1992. JAMA 1992; 268: 2069-2073.
14. Feinstein AR, et al. A controlled study of three methods of prophylaxis agains streptococcal infection in a population of rheumatic children. N Engl J Med 1959; 260: 697-701.
15. Wood HF, Feinstein AR, Taranta A, Epstein JA, Simpson R. Rheumatic fever in children and adolescents: A long-term epidemiological study of subsequent prophylaxis, streptococcal infections and clinical sequelae: III. Comparative effectiveness of three prophylaxis regimens in preventing streptococcal infections and rheumatic fever recurrences. Ann Intern Med 1964; 60: Suppl 5, 31-46.
16. Feinstein AR. Prophylaxis of recurrent rheumatic fever. Ineffectiveness of intermittent 'therapeutic' oral penicillin. JAMA 1965; 191: 451-454.
17. Feinstein AR, Spagnuolo M, Jonas S, Kloth H, Tursky E, Levitt MSO. Prohylaxis of recurrent rheumatic ever. Therapeutic-continous oral penicillin vs monthly injections. JAMA 1968; 206: 565-568.
18. Lue HC, Wu MH, Wang JK, Wu FF, Wu YN. Three- versus four-week administration of benzathine penicillin G: effects on incidence of streptococcal infections and recurrences of rheumatic fever. Pediatrics 1996; 97: 984-988.
19. Kassem AS, Zaher SR, Abou Shleib H, el-Kholy AG, Madkour AA, Kaplan EL. Rheumatic fever prophylaxis using benzathine penicillin G (BPG): two-week versus four-week regimens: comparison of two brands of BPG. Pediatrics 1996; 97: 992-995.
20. Lue HC, Wu MH, Hsieh RP, Chiou JF. Rheumatic fever recurrences: controlled study of 3-week versus 4-week benzathine penicillin prevention programs. J Pediatr 1986; 108: 299-304.
21. Lue HC, Wu MH, Wang JK, Wu FF, Wu YN. Long-term outcome of patients with rheumatic fever receiving benzathine penicillin G prophylaxis every three weeks versus every 4 weeks. J Pediatr 1994; 125: 812-816.
22. Phair JP, Carleston J, Weihl C. Penicillin phenoxymethyl. Use in rheumatic fever prophylaxis. Am J Dis Child 1973; 126: 48-50.
23. Idsoe O, Guthie T, Wilcox RR, De Weck AL. Nature and extent of penicillin side-reactions, with particular reference to fatalities from anaphylactic shock. Bull World Health Organ 1968; 38: 159-188.
24. International Rheumatic Fever Study Group. Allergic reactions to long-term benzathine penicillin prophylaxis for rheumatic fever. Lancet 1991; 337: 1308-1310.
25. Stollerman GH, Rusoff JH, Hirschfield I. Prophylaxis agains Group A streptococci in rheumatic fever. The use of single monthly injections of benzathine penicillin G. N Engl J Med 1955; 252: 787-792.
26. Kaplan EL, Berrios X, Speth J, Siefferman T, Guzman B, Quesny F. Pharmacokinetics of benzathine penicillin G: serum levels during the 28 days after intramuscular injection of 1 200 000 units. J Pediatr 1989; 115: 146-150.
27. Meira ZMA, Mota CD, Torrelli E, Nunan EA, Mitre AM, Moreira NS. Evaluation of secondary prophylactic schemes, based on benzathine penicillin G, for rheumatic fever in children. J Pediatr 1993; 123: 156-158.